Larimar Therapeutics, Inc.

$LRMR which has been trading in a range between about $7 – $8.50 in the month of May, is up today after the FDA had removed a partial clinical hold on Larimar’s nomlabofusp clinical program yesterday after the close.

Share This Article

 

About the Author

Larimar Therapeutics, Inc.

Joey Ramson